Cover Image

Benefits and risks of low molecular weight heparin use on reproductive outcomes: A retrospective cohort study

Objective: Low molecular weight heparin (LMWH) has been given to reproductive-age women with various indications. This study aims to assess the benefits and risks of such use. Materials and methods: We retrospectively reviewed data (n = 204) between Jan 2016 and May 2019. Logistic regression analysi...

Full description

Saved in:

Bibliographic Details
Main Authors:	Ming Chen (Author), Yi-Ting Chen (Author), Chun-Min Chen (Author), Wan-Ju Wu (Author), Wen-Hsiang Lin (Author), Gwo-Chin Ma (Author)
Format:	Book
Published:	Elsevier, 2022-09-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Low molecular weight heparin in COVID-19: benefits and concerns
by: Adham Makarem, et al.
Published: (2023)

Relationship between low molecular weight heparin calcium therapy and prognosis in severe acute kidney injury in sepsis: Mendelian randomized analysis and retrospective study
by: Jian-Chun Li, et al.
Published: (2024)

Effect of low-molecular-weight heparin in women undergoing frozen-thawed embryo transfer cycles: a retrospective cohort study
by: Bo Sun, et al.
Published: (2023)

POSSIBILITIES OF USING LOW-MOLECULAR-WEIGHT HEPARIN IN THE COMPLEX TREATMENT OF WOMEN WITH TUMORS OF THE REPRODUCTIVE SYSTEM
by: A. G. Kedrova, et al.
Published: (2017)

COVID-19 in pregnant women after assisted reproductive technologies receiving low molecular weight heparins
by: N. S. Stuleva, et al.
Published: (2021)

Heparin, Low Molecular Weight Heparin, and Non-Anticoagulant Derivatives for the Treatment of Inflammatory Lung Disease
by: Janis Kay Shute
Published: (2023)

COVID-19, Low-Molecular-Weight Heparin, and Hemodialysis
by: Alessandra F. Perna, et al.
Published: (2020)

Heparin-induced thrombocytopenia associated with low-molecular-weight heparin: clinical feature analysis of cases and pharmacovigilance assessment of the FAERS database
by: Leping Liu, et al.
Published: (2023)

Effects of low-molecular-weight heparin and unfractionated heparin on patients with exertional heat stroke with thrombocytopenia: A prospective study
by: Li Cheng, et al.
Published: (2019)

The effect of subcutaneous injection duration on patients receiving low-molecular-weight heparin: Evidence from a systematic review
by: Li-juan Yi, et al.
Published: (2016)

Non-Anticoagulant Activities of Low Molecular Weight Heparins-A Review
by: Ke Feng, et al.
Published: (2023)

The role of low molecular weight heparin on recurrent pregnancy loss: A systematic review and meta-analysis
by: Fangfei Jiang, et al.
Published: (2021)

Cost-effectiveness analysis of direct oral anticoagulants versus low-molecular-weight heparin and no thromboprophylaxis in primary prevention of cancer-associated venous thromboembolism in China
by: Yue Wu, et al.
Published: (2024)

Analysis on Clinical Outcomes of Low-Molecular Weight Heparin Combined with Magnesium Sulfate in Patients with Pre-Eclampsia
by: Ningning Wang, et al.
Published: (2022)

Preliminary Experience With Low Molecular Weight Heparin Strategy in COVID-19 Patients
by: Pasquale Paolisso, et al.
Published: (2020)

Development of subcutaneous sustained release nanoparticles encapsulating low molecular weight heparin
by: Satheesh Jogala, et al.
Published: (2015)

Low-molecular-weight heparin for the prevention of preeclampsia in high-risk pregnancies without thrombophilia: a systematic review and meta-analysis
by: Jiahui Chen, et al.
Published: (2024)

Prescriber perceptions of the safety and efficacy of unfractionated heparin versus low molecular weight heparin in the acute treatment phase: a qualitative study
by: Danielle Green, et al.
Published: (2024)

An Ovarian Cancer Patient Presenting Heparin - Induced Thrombocytopenia after use of Low - Molecular - Weight Heparin: A Case Report of Rare Condition
by: Yasin Durmuş, et al.
Published: (2019)

High sulfation and a high molecular weight are important for anti-hepcidin activity of heparin
by: Michela eAsperti, et al.
Published: (2016)

Low molecular weight heparins in cancer patients: to treat thromboembolic events, the tumor, or both?
by: Sergio Siragusa
Published: (2011)

Low molecular weight heparins in cancer patients: to treat thromboembolic events, the tumor, or both?
by: Sergio Siragusa
Published: (2011)

Novel Experimental and Clinical Therapeutic Uses of Low-Molecular-Weight Heparin/Protamine Microparticles
by: Shingo Nakamura, et al.
Published: (2012)

Effects of Enzymatically Depolymerized Low Molecular Weight Heparins on CCl4-Induced Liver Fibrosis
by: Yishu Yan, et al.
Published: (2017)

Case Report: Spontaneous Intramural Hematoma of the Colon Secondary to Low Molecular Weight Heparin Therapy
by: Ye Zhu, et al.
Published: (2021)

Safety and Efficacy of Low Molecular Weight Heparin for Thromboprophylaxis in the Elderly: A Network Meta-Analysis of Randomized Clinical Trials
by: Hui-qin Yang, et al.
Published: (2021)

Women's values and preferences on low-molecular-weight heparin and pregnancy: a mixed-methods systematic review
by: Montserrat León-García, et al.
Published: (2022)

Advisory Board conclusion following the discussion "Controversial issues of low molecular weight heparins use in obstetrics"
by: article Editorial
Published: (2021)

Intramural Bowel Hematoma Presenting as Small Bowel Obstruction in a Patient on Low-Molecular-Weight Heparin
by: Beatrix Hyemin Choi, et al.
Published: (2018)

Pharmacoeconomical analysis of use of the low-molecular weight heparins for prevention of the venous tromboembolism in the conditions of multidisciplinary hospital
by: A. S. Kolbin, et al.
Published: (2015)

Alternatives to Low Molecular Weight Heparin for Anticoagulation in Pregnant Women with Mechanical Heart Valves in Middle-Income Countries: A Cohort Study
by: Anish Keepanasseril, et al.
Published: (2021)

VENOUS THROMBOEMBOLISM IN RELATION TO OVARIAN HYPERSTIMULATION SYNDROME: AN APPROACH TO DETERMINING THE LOW-MOLECULAR-WEIGHT-HEPARIN DOSES AND ACTIVITY
by: I. E. Zazerskaya, et al.
Published: (2016)

Nanoparticle-based delivery enhances anti-inflammatory effect of low molecular weight heparin in experimental ulcerative colitis
by: Tawfek Yazeji, et al.
Published: (2017)

Primary prevention of venous thromboembolism with low molecular weight heparins in surgical patients - 2024: Council of Experts resolution
by: А. S. Petrikov, et al.
Published: (2024)

Low-molecular-weight heparin and aspirin use in relation to pregnancy outcome in women with systemic lupus erythematosus and antiphospholipid syndrome: A cohort study
by: Carolien N. H. Abheiden, et al.
Published: (2017)

Body-Weight Gain in Women During Smoking Cessation Is a Sex-Specific Predictor of 6-Month Abstinence: A Retrospective Cohort Study
by: Chin-Wei Kuo, et al.
Published: (2022)

Heparin and Heparin-Based Drug Delivery Systems: Pleiotropic Molecular Effects at Multiple Drug Resistance of Osteosarcoma and Immune Cells
by: Natalia Todosenko, et al.
Published: (2022)

ECONOMIC EVALUATION OF THE EFFECTIVENESS OF LOW MOLECULAR WEIGHT HEPARIN AND INTERMITTENT PNEUMATIC COMPRESSION IN WOMEN IN A CYCLE OF IN VITRO FERTILIZATION
by: A. P. Momot, et al.
Published: (2015)

Obesity as a Risk Factor in the Appearance of Haematomas Caused by Low-Molecular-Weight Heparin: A Cross-Sectional Study
by: Candelaria de la Merced Díaz-González
Published: (2023)

Assessment of the effects of low molecular heparins in pulmonary embolism prophylaxis
by: Michał Piwoński, et al.
Published: (2019)